aid: vascular-therapies
name: Vascular Therapies
description: >-
  Vascular Therapies, Inc. is a privately held, clinical-stage biopharmaceutical
  company headquartered in Cresskill, New Jersey, developing Sirogen, a
  proprietary sirolimus formulation delivered from a bioabsorbable collagen
  implant placed perivascularly at the time of surgery. The product is aimed at
  reducing surgical stenosis and improving arteriovenous fistula maturation and
  patency in end-stage renal disease patients who need hemodialysis vascular
  access. Sirolimus for dialysis vascular access carries FDA Fast Track status
  and Orphan Drug designation in both the United States and the European Union.
  The company ran the Phase 3 ACCESS trial (243 ESRD patients across 20 US
  sites) and the multinational Phase 3 ACCESS 2 trial, whose topline results
  presented in April 2025 did not meet the primary clinical fistula maturation
  endpoint. Vascular Therapies is a therapeutics developer, not a software
  company: it ships a drug-device combination product through clinical trials
  and regulatory review, and publishes no API, SDK, developer portal or
  machine-readable contract of any kind.
url: https://raw.githubusercontent.com/api-evangelist/vascular-therapies/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
x-company-domain: vasculartx.com
x-company-domain-status: >-
  Offline as of 2026-09-02. www.vasculartx.com returns Webflow's
  unpublished-domain "404 - Page not found" catch-all for the site root and for
  every indexed path (/about, /news, /robots.txt); the apex vasculartx.com is
  CNAMEd to proxy-ssl.webflow.com and returns nginx 403 Forbidden for every
  path. Not wired as a Website pointer because a confirmed dead page is a false
  claim, not a web presence.
x-harvest-source-listing: >-
  https://forgeglobal.com/vascular-therapies_stock/ — the secondary-market
  listing this company was harvested from. Deliberately NOT wired as
  type Website: a trading-venue listing page is not the company's own web
  presence, and crediting it as one is the roadmap#56 false-credit defect.
specificationVersion: '0.20'
created: '2026-09-02'
modified: '2026-09-02'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Medical Devices
- Drug Delivery
- Clinical Trials
- Nephrology
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common: []
x-enrichment:
  date: '2026-09-02'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Vascular Therapies is a clinical-stage biopharma developing Sirogen, a
    sirolimus-eluting collagen implant for hemodialysis vascular access — there
    is no software product to expose an API for, and its own web presence is
    additionally offline, with www.vasculartx.com returning Webflow's
    unpublished-domain 404 catch-all on the site root and on every indexed path.
  evidence:
    - url: https://www.vasculartx.com/
      status: 404
    - url: https://www.vasculartx.com/news
      status: 404
    - url: https://vasculartx.com/
      status: 403
    - url: https://vasculartx.com/openapi.json
      status: 403
    - url: https://vasculartx.com/.well-known/agent-card.json
      status: 403
    - url: https://api.vasculartx.com/
      status: 0
    - url: https://developer.vasculartx.com/
      status: 0
    - url: https://github.com/vasculartx
      status: 404
  checked: '2026-09-02'